PI
-
How We Manage Newly Diagnosed Multiple Myeloma With Circulating Tumor Cells
van de Donk, N. W. C. J., 1 Mar 2023, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 41, 7, p. 1342-1349Research output: Contribution to journal › Review article › Academic › peer-review
-
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents
Cohen, A. D., Mateos, M-V., Cohen, Y. C., Rodriguez-Otero, P., Paiva, B., van de Donk, N. W. C. J., Martin, T., Suvannasankha, A., de Braganca, K. C., Corsale, C., Schecter, J. M., Varsos, H., Deraedt, W., Wang, L., Vogel, M., Roccia, T., Xu, X., Mistry, P., Zudaire, E., Akram, M., & 4 others, 19 Jan 2023, In: Blood. 141, 3, p. 219-230 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study
Nahi, H., Usmani, S. Z., Mateos, M-V., van de Donk, N. W. C. J., Oriol, A., Plesner, T., Bandyopadhyay, N., Hellemans, P., Tromp, B., Nnane, I., Zemlickis, D., Chari, A. & Moreau, P., 2023, In: Leukemia and Lymphoma. 64, 2, p. 468-472 5 p.Research output: Contribution to journal › Letter › Academic › peer-review
- All publications